Abstract
About 20–40 % of patients with brain tumor have seizures; all of whom must be treated with antiepileptic drugs (AEDs) that can cause side effects which may influence quality of life (QoL). However, little data are available regarding the weight of epilepsy on QoL in brain tumor (BT) patients, despite the fact that epilepsy is considered the most important risk factor for long-term disability in this patient population. Aim of this study is to explore the weight of epilepsy in BT patients, and to identify which factors might contribute to their epilepsy burden, as expressed by them only at their first visit in a specialized epilepsy center, in order to have a snapshot for that moment in their care cycle. We reviewed medical charts and results from a battery of tests (routinely given at our outpatient center), administered to 100 consecutive BTRE patients at their first visit, followed from 2007 to 2010. Our results reveal: (1) neurological performances and global neurocognitive status were not influenced by factors related to neoplastic disease or to epilepsy (2) side effects, cognitive deficits, and QoL concerns, as well as patients’ perception of these, were significantly related to polytherapy, especially in patients who had been taking AEDs for a period longer that 6 months (3) the seizure number did not influence patients’ QoL. We found that the weight of epilepsy in BTRE patients was related to AED therapy. Our study highlights the fact that epilepsy in our patients adds a significant burden, and suggests the need to give the proper attention to patients’ concerns regarding the challenges that this pathology might present. Nevertheless, future studies could be designed with a follow-up period and with a patient stratification in order to better understand the weight of epilepsy for these patients.
Similar content being viewed by others
References
Maschio M, Dinapoli L (2012) Patients with brain tumor-related epilepsy. J Neurooncol 109:1–6
Gehring K, Aaronson NK, Taphoorn MJ, Sitskoorn MM (2010) Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Rev Anticancer Ther 10:1779–1795
Maschio M (2012) Brain tumor-related epilepsy. Curr Neuropharmacol 10:124–133
Taillibert S, Laigle-Donadey F, Sanson M (2004) Palliative care in patients with primary brain tumors. Curr Opin Oncol 16:587–592
Maschio M, Dinapoli L, Zarabla A et al (2008) Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 86:61–70
Finocchiaro CY, Petruzzi A, Lamperti E et al (2012) The burden of brain tumor: a single-institution study on psychological patterns in caregivers. J Neurooncol 107:175–181
Budrukkar A, Jalali R, Dutta D et al (2009) Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol 95:413–419
Goebel S, Stark AM, Kaup L, von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psycho-Oncology 20:623–630
Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520
Meador KJ (2006) Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 68:63–67
Perucca E, Meador KJ (2005) Adverse effects of antiepileptic drugs. Acta Neurol Scand Suppl 181:30–35
Berg AT, Berkovic SF, Brodie MJ et al (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005–2009. Epilepsia 51:676–685
Karnofsky DA, Burchenal JH, Armistead GC Jr et al (1951) Triethylene melamine in the treatment of neoplastic disease. Arch Int Med 87:477–516
Mahoney FI, Barthel DW (1965) Functional evaluation: the barthel index. Md State Med J 4:61–65
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P (1998) Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 9:549–557
Cramer JA, Van Hammée G, N132 Study Group (2003) Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav 4:118–123
Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62:23–27
Haag A, Strzelczyk A, Bauer S, Kühne S, Hamer HM, Rosenow F (2010) Quality of life and employment status are correlated with antiepileptic monotherapy versus polytherapy and not with use of “newer” versus “classic” drugs: results of the “Compliant 2006” survey in 907 patients. Epilepsy Behav 19:618–622
McCagha J, Fisk JE, Baker GA (2009) Epilepsy, psychosocial and cognitive functioning. Epilepsy Res 86:1–14
Beghi E (2004) Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 3:618–621
French JA, Kanner AM, Bautista J et al (2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology 62:1261–1273
Khan F, Amatya B (2013) Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour. J Neurooncol 111:355–366
Giovagnoli AR (2012) Investigation of cognitive impairments in people with brain tumors. J Neurooncol 108:277–283
Papagno C, Casarotti A, Comi A, Gallucci M, Riva M, Bello L (2012) Measuring clinical outcomes in neuro-oncology. A battery to evaluate low-grade gliomas (LGG). J Neurooncol 108:269–275
Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Khodadadi M (2012) Comparative assessment of neuro-cognitive impairments among patients with brain tumor and healthy adults. Turk Neurosurg 22:309–316
Witt JA, Alpherts W, Helmstaedter C (2013) Computerized neuropsychological testing in epilepsy: overview of available tools. Seizure 22:416–423
Motamedi G, Meador K (2003) Epilepsy and cognition. Epilepsy Behav 4:25–38
Elger CE, Helmstaedter C, Kurten M (2004) Chronic epilepsy and cognition. Lancet Neurol 3:663–672
Acknowledgments
The Authors wish to thank Ms. Lesley Pritikin for reviewing the manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maschio, M., Sperati, F., Dinapoli, L. et al. Weight of epilepsy in brain tumor patients. J Neurooncol 118, 385–393 (2014). https://doi.org/10.1007/s11060-014-1449-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-014-1449-7